Innovations_in_Molecular_Mechanisms_and_Tissue_Engineering_(Stem_Cell_Biology_and_Regenerative_Medicine)

155

rophage phenotype following spinal cord contusion injury. J Neurosci 34:4822–4836.

doi: 10.1523/JNEUROSCI.4369-13.2014

48. Curinga GM, Snow DM, Mashburn C et al (2007) Mammalian-produced chondroitinase AC
    mitigates axon inhibition by chondroitin sulfate proteoglycans. J Neurochem 102:275–288.
    doi: 10.1111/j.1471-4159.2007.04530.x


49. Donnelly EM, Strappe PM, McGinley LM et al (2010) Lentiviral vector-mediated knockdown
    of the NG2 [corrected] proteoglycan or expression of neurotrophin-3 promotes neurite out-
    growth in a cell culture model of the glial scar. J Gene Med 12:863–872. doi: 10.1002/jgm.1509


50. Wiessner C, Bareyre FM, Allegrini PR et al (2003) Anti-Nogo-A antibody infusion 24 hours
    after experimental stroke improved behavioral outcome and corticospinal plasticity in nor-
    motensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 23:154–165.
    doi: 10.1097/00004647-200302000-00003


51. Lee J-K, Kim J-E, Sivula M, Strittmatter SM (2004) Nogo receptor antagonism promotes
    stroke recovery by enhancing axonal plasticity. J Neurosci 24:6209–6217. doi: 10.1523/
    JNEUROSCI.1643-04.2004


52. Lenzlinger PM, Shimizu S, Marklund N et al (2005) Delayed inhibition of Nogo-A does not
    alter injury-induced axonal sprouting but enhances recovery of cognitive function following
    experimental traumatic brain injury in rats. Neuroscience 134:1047–1056


53. Caroni P, Schwab ME (1988) Antibody against myelin associated inhibitor of neurite growth
    neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1:85–96.
    doi: 10.1016/0896-6273(88)90212-7


54. Liebscher T, Schnell L, Schnell D et al (2005) Nogo-A antibody improves regeneration and
    locomotion of spinal cord-injured rats. Ann Neurol 58:706–719. doi: 10.1002/ana.20627


55. Fouad K, Klusman I, Schwab ME (2004) Regenerating corticospinal fi bers in the Marmoset
    ( Callitrix jacchus ) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1.
    Eur J Neurosci 20:2479–2482. doi: 10.1111/j.1460-9568.2004.03716.x


56. Freund P, Schmidlin E, Wannier T et al (2006) Nogo-A-specifi c antibody treatment enhances
    sprouting and functional recovery after cervical lesion in adult primates. Nat Med 12:790–
    792. doi: 10.1038/nm1436


57. McKerracher L, Higuchi H (2006) Targeting Rho to stimulate repair after spinal cord injury.
    J Neurotrauma 23:309–317. doi: 10.1089/neu.2006.23.309


58. Dergham P, Ellezam B, Essagian C et al (2002) Rho signaling pathway targeted to promote
    spinal cord repair. J Neurosci 22:6570–6577


59. Monnier PP, Sierra A, Schwab JM et al (2003) The Rho/ROCK pathway mediates neurite
    growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS
    glial scar. Mol Cell Neurosci 22:319–330. doi: 10.1016/S1044-7431(02)00035-0


60. Sung J-K, Miao L, Calvert JW et al (2003) A possible role of RhoA/Rho-kinase in experi-
    mental spinal cord injury in rat. Brain Res 959:29–38. doi: 10.1016/S0006-8993(02)03717-4


61. Chan CCM, Khodarahmi K, Liu J et al (2005) Dose-dependent benefi cial and detrimental
    effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spi-
    nal cord injury. Exp Neurol 196:352–364. doi: 10.1016/j.expneurol.2005.08.011


62. Borisoff JF, Chan CC, Hiebert GW et al (2003) Suppression of Rho-kinase activity promotes
    axonal growth on inhibitory CNS substrates. Mol Cell Neurosci 22:405–416. doi: 10.1016/
    S1044-7431(02)00032-5


63. Nishio T (2009) Axonal regeneration and neural network reconstruction in mammalian
    CNS. J Neurol 256:306–309. doi: 10.1007/s00415-009-5244-x


64. Addington C, Roussas A, Dutta D, Stabenfeldt S (2015) Endogenous Repair Signaling after
    Brain Injury and Complementary Bioengineering Approaches to Enhance Neural
    Regeneration. Biomark Insights 10:43. doi: 10.4137/BMI.S20062.Received


65. Klusman I, Schwab ME (1997) Effects of pro-infl ammatory cytokines in experimental spinal
    cord injury. Brain Res 762:173–184. doi: 10.1016/S0006-8993(97)00381-8


66. Skaper SD (2012) The neurotrophin family of neurotrophic factors: an overview. Methods
    Mol Biol 846:1–12. doi: 10.1007/978-1-61779-536-7_1

7 Regenerative Strategies for the Central Nervous System

http://www.ebook3000.com